GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Peterlabs Holdings Bhd (XKLS:0171) » Definitions » Debt-to-Revenue

Peterlabs Holdings Bhd (XKLS:0171) Debt-to-Revenue : 0.10 (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Peterlabs Holdings Bhd Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Peterlabs Holdings Bhd's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was RM17.9 Mil. Peterlabs Holdings Bhd's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was RM0.8 Mil. Peterlabs Holdings Bhd's annualized Revenue for the quarter that ended in Dec. 2024 was RM181.5 Mil. Peterlabs Holdings Bhd's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 0.10.


Peterlabs Holdings Bhd Debt-to-Revenue Historical Data

The historical data trend for Peterlabs Holdings Bhd's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peterlabs Holdings Bhd Debt-to-Revenue Chart

Peterlabs Holdings Bhd Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.11 0.08 0.12 0.11

Peterlabs Holdings Bhd Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.10 0.13 0.12 0.10

Competitive Comparison of Peterlabs Holdings Bhd's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Peterlabs Holdings Bhd's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peterlabs Holdings Bhd's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Peterlabs Holdings Bhd's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Peterlabs Holdings Bhd's Debt-to-Revenue falls into.


;
;

Peterlabs Holdings Bhd Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Peterlabs Holdings Bhd's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(17.882 + 0.788) / 176.031
=0.11

Peterlabs Holdings Bhd's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(17.882 + 0.788) / 181.476
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.


Peterlabs Holdings Bhd Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Peterlabs Holdings Bhd's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Peterlabs Holdings Bhd Business Description

Traded in Other Exchanges
N/A
Address
Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800
Peterlabs Holdings Bhd is a Malaysia-based company engaged in the manufacturing, distribution, and trading of animal health and nutrition products. It also provides solutions like farm management, technical advisory services, raw material analysis, and feed formulation. The operating segments of the group are Manufacturing which relates to the manufacturing of animal health and nutrition products, and Trading which relates to the trading and distribution of animal health and nutrition products. It offers products like animal feed additives, veterinary pharmaceuticals, injectable products, multi-nutrient and supplements, topical dressings, cleansing agents, and other related products. The company operates in Malaysia and internationally and generates key revenue from the Trading segment.

Peterlabs Holdings Bhd Headlines

No Headlines